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The notion that pregnancy and abortion are forms of doping has persisted for 20 
years. Popular and scientific literature on pregnancy/abortion doping was criti-
cally analyzed to compare pregnancy/abortion doping with definitions of doping 
and blood doping and to compare pregnancy/abortion doping themes to current 
scientific knowledge. Main themes included oxygenation advantage and hormonal 
advantage. During pregnancy, maximal oxygen uptake may improve but not exer-
cise performance. Human chorionic gonadotropin, the only pregnancy hormone on 
National Collegiate Athletic Association and United States Anti-Doping Agency 
banned substances lists, increases during pregnancy but there is no evidence that 
hCG enhances athletic performance in women. Recommendations include revising 
USADA and NNCAA policies into congruence with World Anti-Doping Agency 
policies which ban hCG for men only.
During the past seven years of advocating for college student-athlete athletic depart-
ment pregnancy and parenting policies, popular nonscientific literature (websites, 
blogs, and personal anecdotes) and scientific literature have been examined to 
detect barriers to student-athlete health and policy change. One barrier is a per-
sistent belief in popular literature that athletes can use pregnancy and/or abortion 
to enhance competitive performance; i.e., as a form of prohibited blood doping. 
The scientific and nonscientific resources on pregnancy and abortion doping have 
considerably diverged over the past 20 years. The purposes of this paper were to 
examine the biophysical themes in popular and scientific definitions of doping, 
blood doping, and pregnancy/abortion doping, compare pregnancy/abortion doping 
to current scientific knowledge, and make recommendations to the stakeholders: 
student-athletes, coaches, athletic trainers, team physicians, athletic and university 
administrators, university faculty, the United States Anti-Doping Agency (USADA) 
and the National Collegiate Athletic Association (NCAA).
The fact that doping has occurred since the beginning of athletic competition 
(e.g., Houlihan, 1999; Public Television transcript, 2008) is not being questioned. 
Excellent analyses of the history of doping (e.g., Franke & Berendonk, 1997; 
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O’Reilly & Madill, 2007; Pablinger & Gruber, 2005) and sociopolitical influences 
on doping (e.g., Houlihan, 1999) are available elsewhere. Numerous scientific pub-
lications have been written on the medical procedures and pharmacological agents 
used in doping, the harmful effects of doping, and the tests used to detect doping 
(e.g., Catlin, Fitch & Ljundqvist, 2008). These important scientific resources serve 
to inform policy makers who enact policies strive to “level the playing field” for 
athletes who compete on the local, national, and international levels. Optimally, 
all stakeholders use the best available scientific evidence to guide their responses 
to conditions which affect the well-being of athletes and sports. Unfortunately the 
stakeholders’ ability to access and use scientific evidence is not always optimal.
First, scientific statements may be misconstrued or misunderstood. In rare 
instances scientists’ statements may have unintended consequences when lay 
individuals use them as the basis for inaccurate statements about emotionally-laden 
topics like pregnancy, abortion, athletic participation and doping. Multiple popular 
literature sources (e.g., Hamilton, 2006; Maxwell, 2002; Mikkelson, 2002; Passig-
nano & Crutcher, 2002; Religious Tolerance, 2002; Webb, 2004; Wolff and O’Brien, 
1994) cited scientists’ statements in support of their reports that pregnancy and 
abortion can be used by athletes as a form of illegal blood doping for competitive 
advantage. Given the frequency of scientific citations, critical review was warranted.
Second, some stakeholders who are seeking information—like pregnant ath-
letes and their partners, parents, coaches, and athletic administrators—may find 
the numerous resources in popular literature more readily accessible and more 
comprehensible than scientific literature which contains academic and medical 
terminology. When scientific literature is uncovered in response to an internet 
search, the literature may only available proprietarily, i.e., for a fee, while popular 
sites are free of cost. The stakeholder may lack sufficient education and critiquing 
skills to effectively assess the scientific credibility of the information source. Thus, 
reviewing both popular and scientific literature on the topic of pregnancy and abor-
tion doping was important to determine lay information and examine congruence 
with scientific literature.
Clearly, pregnancy occurs in the athlete and student-athlete population. Preg-
nancy (their own or their partner’s) occurs to an estimated 10–15% of college 
student-athletes per year (Hogshead-Makar & Sorensen, 2008). Arguably most are 
unintended, precipitating a crisis resulting in destabilized coping (Sorensen, Sincoff 
& Siebeneck, 2009). Considerable anecdotal evidence exists that some student-
athletes respond to the event of pregnancy in unhealthy, unsafe ways: concealing 
pregnancy while continuing to train and compete (Ford, 2004; Lehman College, 
2001; Potts, 2001; Schonbrun, 2007; Willis, 2001), feeling forced to abort (Anony-
mous, 1998; Portnoy, 2004; Rovegno, 2007), feeling forced to choose between 
their financial aid and pregnancy (Rovegno, 2007), and fearing expulsion or other 
negative stereotyping (Anonymous, 1998). Two freshmen student-athletes were 
arrested for the homicides of their term infants (Plushnick-Masti, 2007; Zander 
2007). One student-athlete’s computer memory contained evidence of internet 
searches for pregnancy termination and inducing fetal death (Associated Press, 
2007), supporting the notion that popular literature is a source of information for 
the student-athlete stakeholder. The extent to which the student-athletes mentioned 
above sought out nonscientific information and whether any acted out of fear of 
being accused of pregnancy doping was unclear. While no scientific studies have 
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established student-athletes’ information seeking processes, clearly their decisions 
and actions were not guided by accurate scientific information, legal advice, or 
effective policies.
Yet, national attention to the mistreatment of pregnant student-athletes (e.g., 
Monroe, 2007; Rovegno, 2007) recently motivated the NCAA to advocate for 
student-athlete health by protecting athletic financial aid in the event of pregnancy 
(NCAA, 2008a) and by distributing a comprehensive set of policy guidelines (Hogs-
head-Makar & Sorensen, 2008) to its member institutions. The latter document 
referenced a “short-lived myth that pregnancy enhanced [athletic] performance” 
(Hogshead-Makar & Sorensen, 2008, footnote 1, p. 106). This essay provides 
evidence of the scope of the problem and the “false hypothesis that physiologic 
changes of pregnancy mimic blood doping” (ibid.).
Debunking the myth of pregnancy doping has the potential to positively 
influence athletes’ health and inform policy through providing accurate scientific 
information. Accurate information may potentially increase the likelihood that 
pregnant athletes will seek help rather than conceal their pregnancies. The research 
question guiding this study was, “to what extent are pregnancy and/or abortion 
forms of doping or blood doping?”.
Method
The topic of pregnancy and abortion doping was initially identified in 2004 as a 
potential barrier to healthy student-athlete pregnancy, specifically as a potential 
negative stereotype of pregnant athletes, within a larger search for health and policy 
variables affecting intercollegiate student-athlete pregnancy and parenting. Since 
the phenomenon seemed scientifically unlikely, an initial internet search was con-
ducted in 2006 using the key words “athlete”, “doping” and “pregnancy doping” to 
determine the frequency of nonscientific resources (websites, blogs, media reports 
and anecdotal stories) and examine their content. The first search revealed a sur-
prising number of personal descriptions, citations and attributions of statements 
to individuals identified as scientists, so a second internet search was conducted.
The second internet search used the keywords “abortion doping”, “athlete”, 
“blood doping”, “college student athlete”, “doping”, “doping policy”, “exercise”, 
“pregnant”, “pregnancy”, “pregnancy doping” and the names of specific scientists 
mentioned. The second search was conducted for the purpose of establishing a 
chronological timeline for the proliferation of the phenomenon, examining the cre-
dentials of scientists cited, examining scientific citations, and examining regulatory 
statements and other policy guidelines. Concurrently, a search of academic literature 
was conducted to identify research studies which could establish physiological fac-
tors which might support or refute pregnancy as a performance enhancing condition. 
The search for scientific literature was conducted through a university multiple 
database search engine using the same keywords: “abortion doping”, “athlete”, 
“blood doping”, “college student athlete”, “doping”, “doping policy”, “exercise”, 
“pregnant”, “pregnancy”, “pregnancy doping” and the names of specific scientists 
mentioned. Further searches targeted “human chorionic gonadotropin”, “hCG”, 
and “testosterone”. Literature from maternal-child nursing, obstetrical medicine, 
sports medicine, and sports regulatory bodies were examined. The internet and 
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academic search strategies were repeated four times per year through 2009 to 
detect new resources.
The strength of each data source was assessed using a seven-level evidence 
hierarchy (Polit & Beck, 2008). Systematic reviews of randomized controlled clini-
cal trials were considered the highest level of evidence (Level I). Level II evidence 
consisted of single randomized followed by nonrandomized controlled clinical trials. 
Subsequent levels included systematic reviews of correlational studies (Level III) 
and single correlational studies (Level IV). Systematic reviews of descriptive and 
physiologic studies (Level V) and single descriptive and physiologic studies (Level 
VI) were followed by the lowest level of evidence consisting of the nonpublished 
opinions of experts and authorities (Level VII; Polit & Beck, 2008, p. 31). Internet 
resources were considered scientifically least credible yet were important in estab-
lishing the frequency and chronology of the phenomenon and assessing lay beliefs.
All academic resources were examined to distinguish primary from secondary 
research sources (Polit & Beck, 2008) and retained for critique. Primary sources 
within the past 10 years were considered optimal. Internet resources including 
websites, blogs, media accounts, and personal anecdotes were retained for analysis 
if an author and date could be clearly ascertained. Care was taken to retain an open 
scientific perspective about the potential for truth in the phenomenon, in other words, 
to accept the descriptions in scientific and popular literature without immediate 
prejudice or judgment as to their merit. The literature sources on pregnancy/abortion 
doping were analyzed to extract evidence of purported performance enhancement 
and competitive advantage, and to extract themes.
Results
Defining Doping, Blood Doping and Pregnancy/Abortion 
Doping
Doping. The United States Anti-Doping Agency (USADA; 2006) and World 
Anti-Doping Agency (WADA; 2009a) defined doping as the presence of a 
prohibited substance or its metabolites or markers; refusing of or unavailability 
for sample collection; use or attempted use, possession, trafficking, administration 
or attempted administration of prohibited substances or methods; or tampering 
or attempting to tamper with doping control. The National Collegiate Athletic 
Association (NCAA; 2008b) extended the definition of doping to include 
substances or procedures which artificially induce physiologic advantage or harm, 
and provided a lengthy list of banned drug classes and substances. The NCAA 
Bylaws direct that random, objective, unannounced testing for the presence of 
banned substances should take place regularly in college athletic departments, 
and that purposive objective testing for banned substances is conducted at 
championship events (NCAA, 2008c). A substance or method is banned if it 
enhances performance and/or poses a threat to an athlete’s health (WADA, 2009a). 
The USADA and WADA hold both athletes and their support persons liable for 
violations which include “assisting, encouraging, aiding abetting, and covering 
up or complicity” in an antidoping rule violation (USADA, 2006; p. 3) and for 
consequences of rule violations (WADA, 2009a).
Debunking the Myth of Pregnancy Doping    273
Blood Doping. Blood doping is defined as methods or procedures which 
physiologically enhance the delivery of oxygen to an athlete’s muscles, artificially 
increasing stamina and performance, including increasing red cell mass to 
improve performance (Sawka, Joyner, Miles, Robertson, Spriet & Young, 1996) 
and administration of blood, red blood cells and/or related products to an athlete 
(USADA, 2006). Blood doping may be accomplished by withdrawing blood from 
an athlete at some time before competition, continued athletic training in a depleted 
[anemic] state, then readministration of the athlete’s blood before competition to 
enhance red cell mass and thus oxygen-carrying capacity (USADA, 2006). The 
NCAA (2008b) defines blood doping as the intravenous injection of whole blood, 
packed red blood cells or blood substitutes, and any evidence confirming use. 
The WADA defines blood doping as misuse of techniques and/or substances to 
increase red blood cell mass, which allows the body to transport more oxygen to 
muscles and increase stamina and performance. Specific techniques include the 
use of blood transfusions, and the administration of oxygen carriers and substances 
which stimulate the body to produce more red blood cells, e.g., erythropoietin 
(WADA, 2009b). McGovern, a journalist, defined blood doping as a “well-known 
scheme in which athletes take drugs that enhance their blood supply and oxygen 
supply [for] up to a 10% boost in athletic performance” (2002).
Pregnancy/Abortion Doping. The intent in this section was not to deny the 
existence of past events or critique specific individuals’ beliefs about pregnancy 
or abortion. The intent of this section was to chronicle the progression of reports 
about pregnancy/abortion doping in popular and scientific literature, extract 
themes and scientific arguments used in the reports, and lay a basis for comparison 
with current scientific evidence. For the purposes of this paper, the definition of 
pregnancy/abortion doping was derived from established elements (italicized 
below) of doping and blood doping. Pregnancy/abortion doping are herein defined 
as the misuse of pregnancy and/or abortion by a female athlete, her coach or 
support person to artificially induce physiologic advantage, increase red blood cell 
mass, enhance the delivery of oxygen and boost athletic performance. Pregnancy/
abortion doping would be detected objectively by the presence of a substance (or 
its metabolites or markers) which is listed on the regulatory organization’s list of 
banned drug classes or substances. The definition of pregnancy/abortion doping 
and consequences for this form of doping would extend to anyone who assists, 
encourages, aids, abets, or covers up pregnancy and/or abortion.
Pregnancy/Abortion Doping
Timeline 1988–2008. The earliest statement on pregnancy doping was attributed 
to Dr. Risto Erkkola, a Finnish physician who in 1988 reportedly stated, “now that 
drug testing has become routine, pregnancy has become the favourite [sic] way 
of getting an edge on competitors” (quoted in Hamilton, 2006; Maxwell, 2002; 
Mikkelson, 2002; Passignano & Crutcher, 2002; Religious Tolerance, 2002; Webb, 
2004). Wolff and O’Brien (1994) described in Sports Illustrated the story of Olga 
Karasyova, a 1968 USSR gold medalist in gymnastics, whose coaches ordered 
her to get pregnant then abort at 10 weeks of pregnancy, because pregnancy was 
believed to produce more male hormones which would give her greater strength 
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and stamina. Another frequently cited source on pregnancy and abortion doping 
was Dr. Paul-Erik Paulev, a Danish professor of physiology at the University of 
Copenhagen. Dr. Paulev wrote these 64 words in an 8,040-word Respiratory System 
chapter within his on-line Textbook in Physiology and Pathophysiology (1999b):
Pregnancy seems to increase muscle strength in female athletes. Female top 
athletes—just following the period where they gave birth to their first child—
have set world records. Of course, this is acceptable as a natural and unintended 
event. However, in some countries female athletes have become pregnant for 
2-3 months, in order to improve their performance just following an abortion.
Dr. Paulev’s statements were not referenced to any scientific studies, and repeated 
attempts to contact him personally have been unsuccessful. It is possible that Drs. 
Erkkola and Paulev never intended for their statements to have such great impact.
Passignano and Crutcher (2002) cited Dr. Erkkola as support for the state-
ments that “getting pregnant to abort as a way to improve athletic performance 
is not new. [Pregnancy] increases the volume of oxygen and nutrients in doped 
blood. Pregnancy dopes your blood”. The Life Issues Institute (2002) cited Erkkola, 
Paulev, and Passignano and Crutcher as support for the statements, “recovering 
from abortion takes a few days, then [the athlete is] left with the enhanced muscle 
mass and blood capacity that was meant to carry her through her pregnancy”. The 
American Life League’s Pro-Life Activist’s Encyclopedia (undated) defines preg-
nancy/abortion doping as “[a practice in which] early pregnancy would enhance 
athletic performance. Women are artificially inseminated by coaches, compete in 
events from 5-7 weeks of pregnancy then travel en masse to local abortion mills 
to kill their unborn children”.
McGovern (2002), a journalist, cited Passignano and Crutcher as support for 
the statements, “early pregnancy boosts a woman’s blood volume tremendously. 
Getting pregnant 2-3 months before an event and having an abortion days prior 
[gives] as much as 10% enhancement”. Operation Rescue West (2002a) published 
a news release stating:
Female Olympians routinely get pregnant 2-3 months prior to competition to get 
an edge over the competition. The pregnancy changes a woman’s physiology 
causing a strengthening of the muscle tissue and an extra ‘boost’ of oxygen to 
the athlete’s blood. Then just two weeks before competition, the baby is killed 
by abortion but the physical benefits linger, increasing the athlete’s ability to 
perform. This process is known as ‘blood doping’. Women around the globe 
repeat this cycle of pregnancy and abortion in order to further their careers. 
Olympic ‘heroines’ are routinely built on the bloody foundation of the aborted 
bodies of their own pre-born sons and daughters.
Mikkelson (2002) posed the question, “can female athletes supercharge through 
aborting a fetus just before competition, reabsorbing additional hormones? [This 
practice is] akin to blood doping but in this case it’s hormone levels not red blood 
cells”. Mikkelson reported “delegates’ statements” during the 1988 First Permanent 
World Conference on Anti-Doping in Sport that “some Eastern European female 
athletes were having themselves artificially inseminated then aborting the fetuses 
2-3 months later to take advantage of a perceived hormone boost”. Webb (2004) 
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described abortion doping as “getting pregnant to boost athletic performance. 
Abortion doping enhances the body just like steroids do—by increasing testoster-
one level”, citing Erkkola as support. Abrahamson (2006) wrote that a pregnant 
Russian skier “won three medals at the Salt Lake City Olympic Games in 2002”, 
adding, “medical experts have long known that pregnancy can lead to a measure-
able improvement in an athletic performance—because pregnancy produces an 
abundance of oxygen-carrying red blood cells, boosting endurance. …the ‘effects 
of pregnancy parallel blood doping’ but athletes ‘cease to gain performance ben-
efits after 14 to 15 weeks of gestation”. Hamilton (2006) while discussing elective 
performance enhancement surgeries reported that surgical abortion was “used for 
the purpose of enhancing athletic performance”, and that “pregnancy days prior to 
an event can actually provide as much as a 10% enhancement” (p. 42). Hamilton 
further observed that “the International Olympic Committee has banned it as a 
form of doping” and implied that “other governing organizations … seem to be 
condoning this surgical procedure by their silence” (2006, p. 42). Stanek (2007) 
stated, “It’s a well known fact that female endurance athletes do tend to perform 
better after childbirth”. A Bulgarian tennis athlete tried to explain a high level of 
nandrolone in her blood sample by saying she was pregnant and then miscarried 
(Irish Times, 2007). Epstein (2008) reported in a Sports Illustrated article that,
Doctors now speculate that pregnancy may be a performance enhancer. There is 
evidence that pregnancy can help an athlete. One change in a pregnant woman’s 
body is increased blood volume (because two people are being supplied). Once 
the baby is born, the extra red blood cells that remain in the mother’s system 
carry extra oxygen to the muscles, an effect akin to doping with EPO.
In summary, the phenomenon of pregnancy/abortion doping has been reported 
in the popular literature over the past 20 years and as recently as 2008. Both early 
and recent descriptions of the phenomenon have referred to “scientists”, “doctors” 
or “medical” statements as support for the credibility of the statement. These cita-
tions warrant critical examination.
Major Themes
Two main biophysical themes were extracted from content analysis of the literature 
on pregnancy/abortion doping: an oxygenation advantage and a hormonal advan-
tage. Each theme is discussed below. Current scientific evidence will be used to 
examine each theme’s scientific merit.
Oxygenation Advantage
Pregnancy and/or abortion have been described in popular literature as resulting in 
a competitive advantage related to oxygenation. The oxygenation advantage was 
reported to enhance athletic performance as much as 10% (Passignano & Crutcher, 
2002). Pregnancy-doped blood was reported to contain an increased volume of 
oxygen and nutrients (Life Issues Institute, 2002; McGovern, 2002; Passignano 
& Crutcher, 2002). Early pregnancy was described as a time of increased blood 
volume, cardiac output and oxygen availability (McGovern, 2002).
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Current scientific evidence on pregnancy and specifically early pregnancy 
supports an increase in total blood volume and suggests improved maximal oxygen 
uptake but does not support a conclusion of athletic performance enhancement. 
Frye (1997) explains:
The amount of blood in a pregnant woman’s circulation increases as pregnancy 
advances, with peak volume occurring at 28 to 30 weeks [of a 40 week term 
pregnancy]. Blood volume increases from about 3.5 to 5.6 quarts for a woman 
whose pre-pregnant weight was 130 pounds. This occurs because the mother’s 
body must provide support for the enlarging placenta: supporting placental 
growth, fetal growth, and protecting against [cardiovascular] shock during 
birth. Blood volume expansion is primarily plasma, which begins to increase 
at about 8 weeks of pregnancy at plateaus at 28-30 weeks of pregnancy. Red 
blood cell volume begins to rise at 18 weeks of pregnancy and continues to 
rise until term [38-40 weeks]. Plasma volume expands 50-60% and the red 
blood cells, which increase by only 30%, are correspondingly diluted. This 
is the mechanism of the physiologic “anemia” of pregnancy. It is therefore 
normal for hemoglobin [concentration] to drop about two grams [per deciliter] 
by 28 weeks (p. 889).
Thus, if in response to McGovern’s 2002 statement, we define “early preg-
nancy” as before 18 weeks of pregnancy, the increase in total blood volume during 
this time is related to plasma expansion. Plasma does not improve oxygenation. 
When the oxygen-carrying red cell volume begins to rise (about 18 weeks), its total 
increase is outpaced by total plasma volume increase. The 30% expansion in red 
blood cell volume listed above may be optimistic. Gordon (2002) reported that in 
the absence of iron supplementation, red blood cell volume increased only 18%.
Hemoglobin concentration, the oxygen-carrying component of red blood cells, 
normally ranges from 12 to 16 g per deciliter (g/dl) for adult women (Gaedeke, 
1995, p. 375) but drops to 10 g/dl by 28 weeks of pregnancy due to hemodilution. 
After 28 weeks of pregnancy, hemoglobin levels of 10 g/dl are the lower limit of 
normal (Frye, 1997). Hemoglobin levels between 10 and 14 g/dl result in feelings 
of cardiovascular palpitation, shortness of breath on exertion and fatigue (Gaedeke, 
1997). In a study of exercising pregnant individuals (n = 10, mean age 30 ± 3 
years) hemoglobin levels at 25 weeks of pregnancy averaged 10.8 ± 0.3 g/dl before 
exercise and 12.5 ±0.5 g/dl after exercise. At 35 weeks of pregnancy participants’ 
hemoglobin levels averaged 10.8 ± 0.3 g/dl before exercise and 13.0 ± 0.4 g/dl 
after exercise (McMurray, Hackney, Katz, Gall & Watson, 1991). Hemoglobin 
levels higher than 12 g/dl may indicate hemoconcentration; as “pregnancy results 
in a greater-than-normal exercise induced hemoconcentration” (McMurray, et al., 
1991, p. 1454).
An early study of maximal oxygen uptake (VO
2max
) suggested that pregnancy 
might enhance oxygenation. Clapp and Capeless (1991) studied exercise intensity 
and VO
2max
 in a convenience sample of healthy, well-conditioned, nonpregnant rec-
reational athletes (n = 40; age range 26–36 years) using a prospective, longitudinal, 
between-subjects design. Twenty participants became pregnant during the study; 
for these individuals measures were taken prepregnancy and at 6–8 weeks, 12–20 
weeks, and 36–44 weeks postpartum. Twenty participants remained nonpregnant; 
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measures were taken at the beginning and end of a 15–18 month period. Fitness (via 
morning pulse rate and VO
2max
), exercise performance (via heart rate and number of 
minutes exercising daily), and exercise intensity (the product of exercise minutes 
and VO
2max
) were assessed. The two groups were equivalent on all variables before 
pregnancy. Although the authors found that VO
2max
 in the postpartum group was 
significantly higher than in the nonpregnant group, exercise performance signifi-
cantly declined at all time points for the pregnant individuals. Neither exercise time 
nor performance returned to prepregnancy levels for the pregnant group. This study 
could have been strengthened by reporting laboratory results, e.g., hemoglobin 
levels, and participants’ perceived exertion, shortness of breath, and fatigue. It is 
possible that the expectations or motivations of pregnant participants to excel during 
the study introduced a Hawthorne effect (Polit & Beck, 2007, p. 264). Participants 
who did not become pregnant would not have had similar motivations.
In contrast Lotgering, Van Doorn, Struijk, Pool and Wallenburg (1991) studied 
maximal heart rate, oxygen uptake (VO
2
) and ventilation in a group of 33 pregnant 
individuals (mean age 30.9 ± 0.7 years). Each participant’s 7-week postpartum 
performance used as a nonpregnancy comparison value for their bicycle and 
treadmill performances at 16, 25 and 35 weeks of pregnancy. The authors found a 
consistent but nonsignificant decrease in exercise performance over the course of 
pregnancy compared with the postpartum measurement, and no relationship between 
pregnancy status and maximal oxygen uptake (VO
2
). Bessinger, McMurray and 
Hackney (2002) measured maximal VO
2
 at 22 and 33 weeks of pregnancy and 14 
weeks postpartum in a sample of 12 regularly-exercising pregnant individuals (mean 
age 32 ± 4 years). The authors found that VO
2
 at 22 weeks was significantly lower 
than at 33 weeks of pregnancy when at rest but not during exercise. No differences 
related to pregnancy status were found.
In summary, a student-athlete’s oxygenation during early pregnancy can be 
expected to reasonably parallel the scientific descriptions of normal pregnancy. Total 
blood volume before 18 weeks of pregnancy will increase, but the increase will 
consist primarily of plasma rather than oxygen-carrying red blood cells. Beginning 
at 18 weeks, red blood cell increase may range from 18 to 30% (Gordon, 2002), 
depending on iron intake. Athletes should experience the normal physiological 
anemia of pregnancy. Hemoglobin concentration should range around 10 g/dl., with 
resultant normal feelings of fatigue and shortness of breath. Regardless of oxygen-
ation changes, none of the studies supported a conclusion of athletic performance 
enhancement. If, for the sake of counterargument, pregnancy and/or abortion were 
forms of blood doping (defined as techniques and substances that result in elevated 
red blood cells; NCAA, 2008b; USADA, 2008; WADA, 2008) then maternal hema-
tocrit, hemoglobin levels, and exercise tolerance would all be expected to increase 
in “early pregnancy” (e.g., McGovern, 2002) rather than decrease. Therefore the 
Oxygenation Advantage proposition fails the test of boosting athletic performance.
Hormonal Advantage
The second prevalent theme described a hormonal advantage during pregnancy 
which could enhance athletic performance. Several authors have proposed an 
association between pregnancy and increased muscle mass, strength, or stamina 
(Hamilton, 2006; Life Issues Institute, 2002; Mikkelson, 2002; Operation Rescue 
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West, 2002b; Wolff & O’Brien, 1994) possibly as a result of producing more male 
hormones (Wolff & O’Brien, 1994). The increased muscle mass was purported to 
persist postabortion (Life Issues Institute, 2002; Operation Rescue West, 2002b). 
In one story, an athlete attempted to explain the presence of the steroid hormone 
nandrolone by saying she had recently miscarried her pregnancy (Irish Times, 2007).
Current scientific evidence does not support a conclusion of hormonal advan-
tage resulting in performance enhancement. A comprehensive description of the 
complex endocrine mechanisms necessary to initiate and sustain pregnancy is 
beyond the scope of this paper and available elsewhere (e.g., Davidson, London & 
Ladewig, 2008; Frye, 1997). The literature analysis for this paper was focused on 
cross-referencing normal hormones of pregnancy with current authoritative lists 
of banned hormones and substances, then examining the resulting hormones for 
their potential performance-enhancing effects. The hormones of normal pregnancy 
include human chorionic gonadotropin (hCG), human placental lactogen (hPL), 
estrogen, progesterone, and relaxin (Davidson et al., 2008; Frye, 1997). Of these, 
the World Anti-Doping Agency (2009b) bans hCG and its analog leutenizing hor-
mone (LH) for men only. LH is similar in function to hCG (Davidson et al., 2008). 
The USADA (2006) and NCAA (2008) ban hCG for athletes of both genders. The 
scientific bases for these policy differences regarding hCG warrant examination.
Human chorionic gonadotropin (hCG). Human chorionic gonadotropin is 
produced by the anterior pituitary of normal adult men and adult nonpregnant 
women, where normal levels range from 0 to 5 milliunits per milliliter (mIU/ml; 
Frye, 1997, p. 112). In men, hCG acts upon the testes to stimulate testosterone 
production (Kicman, Brooks & Cowan, 1991). The normal total and free 
testosterone levels in men range from 280 to 1100 nanomoles per liter (nm/l, 
Frye, 1997). In a double-blind, randomized clinical study of healthy men with 
normal testosterone levels (n = 61, age range 18–35 years), increased muscle mass, 
strength, and endurance was directly dependent upon testosterone dose (Bhasin, 
Woodhouse, Casaburi, Singh, Bhasin, Berman et al., 2001). In other words hCG is 
clearly performance enhancing in men. Handelsman (2006) explains:
In normal men, hCG produces a sustained and dose-dependent increase in 
blood testosterone concentrations through stimulation of Leydig cell testos-
terone secretion. Typically, the basal blood concentrations (~20 nmol/liter) are 
increased to concentrations of 30-40 nmol/l, peaking between two and four 
days after a single injection. These markedly increased blood testosterone 
concentrations, within 10-30 nmol/l, are with the range defined experimentally 
as having a log-linear relationship with increased muscle mass and strength in 
men. Hence [the doping] prohibition of hCG for men is well justified (p. 1649).
Human chorionic gonadotropin in women. Clearly, hCG produces a clear 
dose-dependent rise in testosterone which enhances performance in men, but 
does a similar relationship occur in women? In nonpregnant normal adult women, 
total blood testosterone levels ranges from 0.52 to 2.43 nmol/l (Frye, 1997, 
p. 357). Filicori, Cognigni, Gamberini, Parmegiani, Troilo and Roset (2005) 
administered a daily dose of 200 IU of hCG to nonpregnant women (n = 48, age 
range 29–39 years). Carmina, Wong, Chang, Paulson, Sauer, Stanczyk and Lobo 
(1997) administered 10, 000 IU of hCG to a group of women with normal ovarian 
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function (n = 15, mean age 28 ± 1 years). In both of these studies, the elevation in 
participants’ blood testosterone level averaged 1.1 nanograms per milliliter (ng/
ml; Carmina et al., 1997; Filicori, et al., 2005), i.e., “about half of the daily normal 
diurnal rhythm in blood testosterone concentration” in women, which is “unlikely 
to have any measurable effect on muscle mass or strength” (Handelsman, 2006, 
p. 1650). Human chorionic gonadotropin has negligible, if any, stimulation of 
blood testosterone concentrations in nonpregnant women (Handelsman, 2006, p. 
1649; Kicman, et al., 1991, p. 78; Stenman, Hotakainen & Alfthan, 2008; p. 569). 
In nonpregnant women, hCG stimulates the ovary to produce progesterone and 
estradiol, not testosterone (Stenman, Hotakainen & Alfthan, 2008). Thus, there is 
no scientific evidence that hCG is performance-enhancing in nonpregnant women.
In pregnant normal adult women, the fertilized, implanted ovum and then the 
placenta produce increasingly elevated levels of hCG, which peaks at 7–10 weeks 
of pregnancy between 25,700–288,000 mIU/ml then gradually declines (Frye, 
1997; Kicman, Brooks & Cowan, 1991). In the second and third trimesters of 
pregnancy, hCG ranges from 4060 to 65,400 mIU/ml and 3640–117,000 mIU/ml 
respectively (Frye, 1997, p. 112). After several days postpartum, hCG returns to 
prepregnant levels. In pregnant women hCG stimulates the production of estrogens 
and progesterone (Davidson et al. 2008; Stenman, Hotakainen & Alfthan, 2008), 
which do not have ergogenic effects. In pregnancy, estrogens cause enlargement of 
the uterus and breasts, and increase uterine & fallopian contractility; progesterone 
decreases uterine contractility and sustains the pregnancy (Davidson et al., 2008).
Summary. The gender-specific scientific evidence on the ergogenic effects of 
hCG, i.e., performance enhancement has been demonstrated in men and not in 
women, may be the reason that the World Anti-Doping Agency currently bans the 
presence of hCG for male athletes only and not for female athletes. The WADA 
may also decline to ban hCG testing for women for ethical reasons. Routine urine 
testing for hCG in female athletes is “considered an invasion of female athlete 
privacy” (Handelsman, 2006, p. 1649) for three reasons: 1.) a lack of scientific 
evidence for hCG-related performance enhancement, 2.) high levels of hCG are 
experienced by normal pregnant women without negative health outcomes, and 
3.) routine testing for hCG can reveal the presence of unexpected pregnancy 
or miscarriage with devastating psychological consequences to the athlete 
(Handelsman, 2006). If, for the sake of counterargument, hCG was performance-
enhancing for women, i.e., pregnancy and its resultant high levels of hCG were 
a form of doping, then all pregnant women would be logically expected to 
develop extraordinary musculature, strength and endurance. Thus, since there is 
no scientific evidence that establishes that hCG has ergogenic effects in women, 
then the Hormonal Advantage proposition fails the test of physiological advantage 
to boost athletic performance.
Minor Themes
Two minor themes were also found during analysis of the literature. The first minor 
theme was a suggestion that there is an optimal timing of pregnancy or abortion 
in order for competitive advantage. The time frames ranged from 5 to 7 weeks 
(American Life League undated), 10 weeks (Wolff & O’Brien, 1994), and 2–3 
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months of pregnancy (Life Issues Institute, 2002; McGovern, 2002; Paulev, 1999). 
The optimal timing of abortion in order for competitive advantage has been reported 
as precompetition (Wolff & O’Brien, 1994), just before competition (Paulev, 1999); 
days or a few days before competition (Life Issues Institute, 2002; McGovern, 
2002; Passignano & Crutcher, 2002) and just after a competition (American Life 
League). The reasons for these varied time frames have no clear basis in science, 
given that pregnancy does not result in performance enhancement.
Moral and ethical failures were the second theme, although failure on whose 
part was inconsistent. Pregnancy/abortion doping was described in popular litera-
ture as immoral (American Life League) and carried out illicitly (Abrahamson, 
2006). Responsibility for pregnancy doping was ascribed to coaches and athletic 
trainers (American Life League). A coach or athletic trainer unethically used power 
over the athlete to artificially inseminate her (American Life League), to order the 
athlete to get pregnant (Wolff & O’Brien, 1994), and to order termination of the 
pregnancy (American Life League; Wolff & O’Brien, 1994). Some authors sug-
gested that pregnancy/abortion doping continues as an athletic practice because 
it is less detectable than other drug tests and impossible to enforce, stop or ban 
(Lifesite, 2002; McGovern, 2002). In some cases pregnancy doping was described 
as the intended goal of an athlete’s pregnancy (American Life League; Life Issues 
Institute, 2002; McGovern, 2002; Wolff & O’Brien, 1994) while others described 
doping as a natural, unintended consequence of pregnancy (Passignano & Crutcher, 
2002; Paulev, 1999). If pregnancy doping was described as the intended goal of 
pregnancy, the decisions to become pregnant and to terminate pregnancy were 
ascribed to coaches (American Life League, undated; Wolff & O’Brien, 1994) or 
to the athlete herself (Life Issues Institute, 2002; Passignano & Crutcher, 2002; 
RealChoice, 2007). Authors that described pregnancy doping as the intended goal 
used more negative words, e.g., horrible, immoral, scheming (McGovern, 2002), 
gruesome (Lifesite, 2002), and abhorrent (Abrahamson, 2006) than those who 
implied that pregnancy doping was an unintended consequence of pregnancy (Pas-
signano & Crutcher, 2002; Paulev, 1999).
Discussion
The persistence of the notion that pregnancy and/or abortion can be used by female 
athletes to improve athletic performance is a barrier to healthy student-athlete 
pregnancy and to the health of sports. The myth seems to have originated within 
early scientific statements (e.g., Erkkola, Paulev) which have now been eclipsed 
by current science. Popular literature as recently as 2008 continues to perpetuate 
the myth and inaccurately portray pregnancy and abortion. A little information can 
sometimes be a dangerous thing.
Although the myth of pregnancy doping has been scientifically debunked, the 
persistent negative characterizations of pregnancy in athletes are of concern for two 
reasons. The first reason is that negative, judgmental character assumptions may 
discourage pregnant athletes from seeking the help they need. Hogshead-Makar 
and Sorensen (2008) argued that an intercollegiate student-athlete’s pregnancy is 
rarely intended. The challenges of unintended pregnancy can cause psychological 
disequilibrium; if unresolved, maladaptive behaviors may result (Messer, Dole, 
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Kaufman & Savitz, 2005). In two separate instances during 2007, freshman intercol-
legiate student-athletes became pregnant, concealed their pregnancies, delivered in 
their dorm rooms, and killed their newborn infants (Plushnick-Masti, 2007; Zander, 
2007). While these two individual athletes’ states of mind cannot be assumed, it 
is possible that the outcomes of their pregnancies were affected by fears of nega-
tive stereotyping, difficulties coping or an unsupportive policy environment. The 
second reason for concern is that these negative characterizations focus exclusively 
on female athletes. Male athletes are potentially equal partners in pregnancy and 
do become parents while in college. The focus on female athletes disregards the 
potentially real concerns of male athletes who may have concerns about their part-
ner’s health during pregnancy and their ethical, financial, and legal responsibilities 
regarding their partner’s pregnancy (Sorensen, Sincoff & Siebeneck, 2009). Moving 
as a nation toward a more appropriate, gender-equitable, ethical response to athlete 
pregnancy must begin with disseminating accurate scientific knowledge. Changing 
the negative stereotypes and existing institutional cultures may take much longer.
Summary
A persistent belief in popular literature from 1988 to 2008 that athletes could or 
would use pregnancy for a form of illegal blood doping was a barrier to healthy 
pregnancy and to the health of the sport. Analysis of the scientific and popular litera-
ture on doping, blood doping, pregnancy and athletics revealed that the proposition 
that a female athlete can gain competitive advantage from pregnancy or abortion 
is unsupported by current science. The two most consistent themes of purported 
oxygenation and hormonal advantage were carefully analyzed against current sci-
ence and compared with existing definitions of doping and blood doping. Minor 
themes in the literature included the timing of pregnancy or pregnancy termination 
and ethical issues. Although pregnancy timing had no basis in science, ethical 
problems were consistently apparent in most of the literature.
Recommendations
It is important to share accurate scientific information about pregnancy—that 
pregnancy and abortion are not doping or blood doping—as soon as possible with 
student-athletes, coaches, athletic trainers, team physicians, athletic and university 
administrators, and university faculty. Hopefully this paper will prepare each stake-
holder to respond to the myth of pregnancy doping with contemporary, accurate 
scientific knowledge. The healthiest, safest athletic culture will consist of stakehold-
ers who are sensitive to the myths and negative characterizations about pregnant 
athletes, and sensitive to the psychological effects of unintended pregnancy. The 
best institutional responses will address the needs of both male and female athletes. 
For research scientists of every discipline in university and other organizational 
settings: this is a time for initiating stakeholder discussions on ethical behavior, 
abuse of power, and ethical institutional response to pregnancy. Critical analyses of 
the scientific and popular literature on a wide variety of topics that impact athletic 
participation are sorely needed to continue breaking down barriers to health. We 
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must continue eating “this particular elephant one bite at a time” (WADA CEO 
referring to doping, quoted in O’Reilly & Madill, 2007; p. 11).
For the USADA and NCAA, recommendations include a continued com-
mitment to healthy athletic participation through banning unsafe substances and 
funding comprehensive efforts to continue objective biophysical testing. Revisions 
to the USADA Athlete Handbook (2006), NCAA Bylaw 31.2.3 (2008b) and the 
NCAA list of banned substances (2008c) to prohibit hCG for men only should 
be considered on the basis of Handelsman’s arguments (2006). These revisions 
will increase USADA and NCAA congruence with World Anti-Doping Agency 
practices, reduce invasion of female athlete privacy, and may potentially reduce a 
pregnant athlete’s fear of violating antidoping rules by testing positive for a banned 
substance (hCG); i.e., violating current USADA and NCAA antidoping rules. The 
fear of violating current antidoping rules could be a motivator to conceal pregnancy. 
The NCAA’s powerful educational resources could support knowledge develop-
ment in student-athletes, coaches, athletic trainers, team physicians, athletic and 
university administrators, and university faculty.
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